ARCHIVES

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

Nurses Must Assist In Pain Management, ONS Says

May 31, 1991

ONS The Largest And Still Growing With 13,000 Members

May 27, 1988

Bladder Cancer Survival Rate Rises With Neoadjuvant Chemo

September 26, 2003

ASCO Releases Guideline On Larynx Preservation

July 28, 2006

Tobacco Company Liggett Gave $3.6 Million To Henschke For CT Screening Research.

March 28, 2008

In Brief: NIH Call For Review Group Nominations Brings 8,000 Names For 400 Vacancies

August 17, 1979